Search results
Turning CO2 Into Chemical Gold: Affordable Nanocatalysts Could Revolutionize Climate Action
SciTechDaily· 5 days agoCarbon dioxide (CO2), a greenhouse gas, plays a significant role in climate change by building up in the atmosphere. To mitigate its impact, transforming CO2 into beneficial carbon products ...
How Editas 'dragged' Linda Burkly over as CSO after 37 years at Biogen
FierceBiotech· 5 days agoLinda Burkly, Ph.D., was 37 years into a career at Biogen when Editas Medicines CEO Gilmore...
Overcoming thermostability challenges in mRNA–lipid nanoparticle systems with piperidine-based...
Nature· 5 days agoPiperidine-based ionizable lipids avoid the formation of mRNA–lipid adduct that is responsible for the loss-of-function of mRNA and contribute to the long-term storage stability of mRNA/LNPs as a wet preparation.
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
WKRN Nashville· 5 days agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer ...
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
Benzinga· 5 days agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 SN, a new drug for polymer
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoNovavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines PR Newswire GAITHERSBURG, Md., May 10, 2024 Agreement provides individuals with broader access
Agreement Signing on Authorization of Rights under | Newswise
Newswise· 2 days agoProf. Dr. Kaywalee Chatdarong, Vice President for Strategic Planning, Innovation and Global...
Novavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoNovavax, Inc. (NASDAQ:NVAX) Q1 2024 Earnings Call Transcript May 12, 2024 Novavax, Inc. isn’t one of...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
The Yuma Sun· 17 hours agoExpanded strategic relationship with Astellas with new research collaboration leveraging Poseida's proprietary allogeneic CAR-T platform to develop cell therapies targeting solid tumors
Revolutionary “Quartet Nanocage” Vaccine Effective Against Coronaviruses That Haven’t Even Emerged...
SciTechDaily· 2 days agoResearchers have created a new vaccine technology that, in tests with mice, has demonstrated...
